Search Within

Ghassan Abou-Alfa

Formats
  1. Meeting Abstract (262)
  2. Journal Article (246)
  3. Review (27)
  4. Book Section (16)
  5. Editorial (8)
  6. Book Whole (4)
  7. Correspondence (4)
  8. Guidelines (4)
  9. Miscellaneous (3)
  10. Research Letter (1)
Groups
  1. Department of Medicine (575)
  2. Gastrointestinal Oncology Service (575)
  3. Solid Tumor Oncology Division (575)
  4. Center for Pancreatic Cancer Research (215)
  5. Epidemiology and Biostatistics (122)
  6. Surgery (103)

More Groups

People
  1. Eileen O'Reilly (156)
  2. James Harding (130)
  3. William Jarnagin (66)
  4. Marinela Capanu (65)
  5. Leonard Saltz (55)
  6. Imane El Dika (54)

More People

Years
  1. 2025 (20)
  2. 2024 (52)
  3. 2023 (48)
  4. 2022 (53)
  5. 2021 (46)
  6. 2020 (46)

More Years

Publications
  1. Journal of Clinical Oncology (166)
  2. Annals of Oncology (53)
  3. Gastrointestinal Cancer Research (21)
  4. Oncology Research and Treatment (18)
  5. Annals of Surgical Oncology (15)
  6. Cancer (14)

More Publications

Publishers
  1. American Society of Clinical Oncology (182)
  2. Oxford University Press (65)
  3. Springer (36)
  4. Wiley Blackwell (30)
  5. Elsevier Inc. (25)
  6. Elsevier Science, Inc. (24)

More Publishers

Results (575)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pancreatic ductal adenocarcinoma (PDAC), BRCA: Detailed analysis and outcomes of cohort from Memorial Sloan Kettering Cancer Center (MSK)
    Meeting Abstract

    Momtaz, P.; O'Connor, C. A.; Chou, J. F.; Capanu, M.; Yu, K. H.; Varghese, A. M.; Park, W.; Zervoudakis, A.; Li, J.; Ku, G. Y.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Circulating free DNA (cfDNA) and tissue next-generation sequencing analysis in a phase II study of infigratinib (BGJ398) for cholangiocarcinoma with FGFR2 fusions
    Meeting Abstract

    Makawita, S.; Kelley, R. K.; Roychowdhury, S.; Weiss, K. H.; Abou-Alfa, G. K.; Macarulla, T.; Sadeghi, S.; Waldschmidt, D.; Zhu, A. X.; Goyal, L.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • A phase II randomized placebo-controlled study investigating the combination of yiv-906 and sorafenib (SORA) in HBV (+) patients (Pts) with advanced hepatocellular carcinoma (HCC)
    Meeting Abstract

    Harding, J. J.; Abou-Alfa, G. K.; Shi, Y.; Whang-Peng, J.; Yuen, M. F.; Saif, W. M.; Tian, A.; Gu, S.; Lam, W.; Liu, S. H.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • FIDES-01, a phase II study of derazantinib in patients with unresectable intrahepatic cholangiocarcinoma (iCCA) and FGFR2 fusions and mutations or amplifications (M/A)
    Meeting Abstract

    Javle, M. M.; Shaib, W. L.; Braun, S.; Engelhardt, M.; Borad, M. J.; Abou-Alfa, G. K.; Boncompagni, A.; Friedmann, S.; Gahlemann, C. G.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Nivolumab (NIVO) and drug eluting bead transarterial chemoembolization (deb-TACE): Preliminary results from a phase I study of patients (pts) with liver limited hepatocellular carcinoma (HCC)
    Meeting Abstract

    Harding, J. J.; Yarmohammadi, H.; Reiss, K. A.; Chou, J. F.; Capanu, M.; Do, R. K. G.; Khalil, D.; El Dika, I. H.; Giardina, J. D.; Merghoub, T.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Pharmacokinetics/pharmacodynamics (PK/PD) of ivosidenib in patients with mutant IDH1 advanced cholangiocarcinoma from the phase III ClarIDHy study
    Meeting Abstract

    Fan, B.; Abou-Alfa, G. K.; Zhu, A. X.; Pandya, S. S.; Jia, H.; Yin, F.; Jiang, L.; Gliser, C.; Yang, H.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Comparative efficacy of cabozantinib and regorafenib for advanced hepatocellular carcinoma
    Journal Article

    Kelley, R. K.; Mollon, P.; Blanc, J. F.; Daniele, B.; Yau, T.; Cheng, A. L.; Valcheva, V.; Marteau, F.; Guerra, I.; Abou-Alfa, G. K.
    Advances in Therapy (2020)

    Fulltext@MSK | Save
  • Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: A multicentre, open-label, phase 2 study
    Journal Article

    Abou-Alfa, G. K.; Sahai, V.; Hollebecque, A.; Vaccaro, G.; Melisi, D.; Al-Rajabi, R.; Paulson, A. S.; Borad, M. J.; Gallinson, D.; Murphy, A. G.; more...
    Lancet Oncology (2020)

    Fulltext@MSK | Save
  • Germline alterations in patients with biliary tract cancers: A spectrum of significant and previously underappreciated findings
    Journal Article

    Maynard, H.; Stadler, Z. K.; Berger, M. F.; Solit, D. B.; Ly, M.; Lowery, M. A.; Mandelker, D.; Zhang, L.; Jordan, E.; El Dika, I.; more...
    Cancer (2020)

    Fulltext@MSK | Save
  • Fight-202: A phase 2 study of pemigatinib in patients (PTS) with previously treated locally advanced or metastatic cholangiocarcinoma (CCA)
    Meeting Abstract

    Vogel, A.; Sahai, V.; Hollebecque, A.; Vaccaro, G.; Melisi, D.; Al-Rajabi, R.; Paulson, A. S.; Borad, M. J.; Gallinson, D.; Murphy, A. G.; more...
    Oncology Research and Treatment (2020)

    Fulltext@MSK | Save